Karuna Therapeutics Inc. (KRTX) Misses Q3 EPS by 27c

Karuna Therapeutics Inc. (NASDAQ: KRTX) reported Q3 EPS of ($2.38), $0.27 worse than the analyst estimate of ($2.11). Revenue for the quarter came in at $81 thousand.

For earnings history and earnings-related data on Karuna Therapeutics Inc. (KRTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c